Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P50583 (
asymmetrical
)
12,197
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
This review analyzes how interplay between folate binding and changes in
folate binding protein
(
FBP
) conformation/self-association affects the biological function of
FBP
. Concentration-dependent, reversible self-association of hydrophobic apo-
FBP
at pI=7.4 is associated with decreased affinity for folate, probably due to shielding of binding sites between interacting hydrophobic patches. Titration with folate removes apo-monomers, favoring dissociation of self-associated apo-
FBP
into apo-monomers. Folate anchors to
FBP
through a network of hydrogen bonds and hydrophobic interactions, and the binding induces a conformational change with formation of hydrophilic and stable holo-
FBP
. Holo-
FBP
exhibits a ligand-mediated concentration-dependent self-association into multimers of great thermal and chemical stability due to strong intermolecular forces. Both ligand and
FBP
are thus protected against biological/physicochemical decomposition. In biological fluids with low
FBP
concentrations, e.g., saliva, semen and plasma, hydrophobic apo-monomers and hydrophilic holo-monomers associate into stable
asymmetrical
complexes with aberrant binding kinetics unless detergents, e.g., cholesterol or phospholipids are present.
...
PMID:The complex interplay between ligand binding and conformational structure of the folate binding protein (folate receptor): Biological perspectives. 2611 48